RATIONALE: Studying samples of blood and urine from patients with cancer and from healthy participants in the laboratory may help doctors identify and learn more about biomarkers related to cancer. PURPOSE: This laboratory study is looking at biomarkers in patients with kidney cancer or cancer of the urothelium and in healthy participants.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Presence of bone morphogenetic protein antagonist regulated in cancer (BARC) in urine and serum samples
BARC expression levels
Correlation of changes in serum markers of iron metabolism with changes in BARC expression
Feasibility of an enzyme-linked immunosorbent assay to detect BARC levels as a diagnostic procedure